- Published on
Infectious Disease - Diphtheria
DIPHTHERIA
Basics: Obstructive laryngotracheitis, which can cause trouble breathing, or pseudomembrane formation on the tonsils, pharynx, larynx, and nasal cavity are signs of an acute upper respiratory tract infection caused by Corynebacterium diphtheriae. Acute tubular necrosis, peripheral neuropathies, and myocarditis are further possible outcomes of infection. C. diphtheriae can also produce lesser skin-only illnesses.
The study of epidemiology
Since 1980, the US has seen an incidence of about 0.001 instances per 100,000 people. Prior to vaccination, in the 1920s, there were between 100–200 cases per 100,000 people.
The frequency
Preschool-aged children have the highest attack rate; recent, infrequent outbreaks have mostly impacted adults; it is still endemic in portions of Africa, the Americas, the Middle East, Asia, the South Pacific, and Europe.
• It is more prevalent during the colder months in temperate zones; in the tropics, seasonal variations are less pronounced.
RISK ELEMENTS
Low socioeconomic position, lack of or insufficient immunization, crowded and filthy living conditions, immunocompromise, and travel to endemic or ongoing epidemic areas, particularly for those without a diphtheria toxoid booster
Genetics
No clear genetic connection to illness
GENERAL PREVENTION • Health education highlighting the risks of contracting diphtheria and the value of vaccination • Immunization with diphtheria toxoid
• Every ten years, diphtheria toxoid is promoted; the government is dedicated to immunization and other public health initiatives.
Tight disease control protocols during outbreaks: Notify the Department of Health of cases; isolate and treat patients
Clean all items that come into contact with the patient; isolate patient contacts who work with food, particularly milk, and those who come into contact with youngsters who are not inoculated; look into the cause of the infection; Preventive care for infection carriers
Pathophysiology
Exotoxin is released by C. diphtheria when it adheres to mucosal epithelial cells; it causes a local inflammatory response that is followed by tissue destruction and necrosis; it causes proteolytic cleavage of the cell membrane, which allows segment A to enter the cell; it inhibits host cell protein synthesis and results in cell death; and it spreads through the lymphatic and hematological systems, causing systemic disease.
Ethiology
• Caused by C. diphtheriae strains infected with a lysogenic bacteriophage virus that carries a gene that codes for a toxin.
• The incubation time is 2–5 days (with a range of 1–10).
C. diphtheriae are aerobic, pleomorphic, Gram-positive, nonmotile bacilli that mostly infect humans.
• The organism may colonize the respiratory tract without causing illness; it is spread via respiratory droplets, contact with nasopharyngeal secretions, exudates from cutaneous lesions, and fomites.
COMMON CONNECTED CIRCUMSTANCES
No conditions that are frequently linked
History of Diagnosis
• Signs, such as chills and fevers
Weakness and malaise; cough, hoarse voice, sore throat, and dysphagia Cervical lymphedema
- Headache - Serosanguineous or purulent nasal discharge - Neck edema - Nasopharyngeal membrane formation - Dyspnea, wheezing
Lesions on the skin
• Travel history; • Immunocompromising conditions; • History of vaccinations, including booster shots;
• Drinking unpasteurized dairy products
Physical examination • Fever of low severity
Swelling of the neck or "bull's neck"; tachycardia; pseudomembrane (grey and adherent) on the tonsils, pharynx, or nasal membranes; bleeding in the underlying mucosa when the pseudomembrane is scraped off; halitosis; cervical lymphadenopathy; respiratory distress symptoms such as stridor, wheeze, cyanosis, and use of accessory muscles; dysrhythmias; indications of infective endocarditis; and deficits in the cranium or peripheral nerves
Initial diagnostic and interpretation lab tests
Moderate leukocytosis is seen in the complete blood count (CBC); temporary proteinuria is seen in the urine analysis.
• Levels of serum troponin-I
• The isolation of C. diphtheriae in culture and the detection of toxin presence serve as the foundation for a conclusive diagnosis.
• C. diphtheriae was isolated using Gram stain, which revealed clusters of club-shaped, nonencapsulated, nonmotile bacilli with a distinctive Chinese character configuration.
Cultures: Use nasal or throat swabs to inoculate tellurite or Loeffler media, then identify the colonies based on their morphology, microscopic appearance, and fermentation reactions.
• Polymerase chain reaction (PCR) for tox genes; Elek test; Toxin detection
Follow-up and Particular Points to Remember
Keep an eye on your CBC and 12-lead ECG.
Imaging first approach: computed topography, ultrasound scan, or chest radiograph; soft tissue radiography of the neck
Follow-up and Particular Points to Remember
Nothing
Diagnostic Tests and Other Services: Patients may need:
Surgical airway procedures such as cricothyroidotomy or tracheostomy; laryngoscopy or bronchoscopy; endotracheal intubation; and electrical pacing for conduction problems
Pathological Results
The tonsils, pharynx, larynx, and nasal mucosa all have pseudomembranes, which can be aspirated into the lungs.
DISTINCTIVE DIAGNOSIS
Vincent's angina, viral pharyngitis, streptococcal pharyngitis, infectious mononucleosis, epiglottitis, infectious endocarditis, and herpes simplex virus
MEDICATION FOR TREATMENT
First Phrase
• Since horses produce diphtheria antitoxin (DAT) and patients may experience a hypersensitive reaction to horse antiserum, DAT should be given as soon as possible. With epinephrine and cardiac resuscitation resources nearby, a test dose is necessary.
• Antibiotics: Penicillin G 300,000 U/d for 14 days in patients under 10 kg i.m.
600,000 U/d for 14 days for patients weighing more than 10 kg i.m.
Erythromycin (for people who are allergic to penicillins) Adult: 500 mg intravenously every six hours for 14 days
Vancomycin for children: 40–50 mg/kg/day p.o./i.v., divided into 6 hourly doses for 14 days
Adult: given intravenously (1 g every 12 hours)
Children: intravenous infusion of 40 mg/kg/d over 1 hour, divided into 6 hourly doses; bronchodilators; antipyrexials; second-line pharmaceutical therapy as described above
ADDITIONAL MEDICATION
Overall Actions
Patients should be isolated as soon as possible. Two large-bore intravenous cannulae should be inserted. Cardiac monitoring should be done.
Referral issues include the following: anesthetist for airway management; surgery for surgical airway; cardiology for myocarditis; respiratory medication for bronchoscopy for pseudomembrane removal or obstruction; renal medication for acute tubular necrosis; and neurology for peripheral nerve damage.
ALTERNATIVE AND COMPLIMENTARY THERAPIES
Physiotherapy for neurological conditions
OTHER PROCEDURES AND SURGERY
Surgical airway may be necessary.
Considering the patient
First Stabilization
Provide patients with adequate resuscitation in accordance with pediatric basic life-support or advanced life support (ALS) procedures.
Requirements for Admission
Individuals with heart failure, septicemia, pulmonary compromise, or symptoms of infective endocarditis
IV fluids; aggressive fluid resuscitation in septic shock patients using colloids, such as Gelofusin
• When necessary, maintenance fluids containing Ringer's lactate
Until two nasopharyngeal swab cultures, obtained 24 and 48 hours after stopping antibiotics, are negative, nurses should isolate patients using universal and droplet precautions.
Criteria for Discharge
• Individuals with the two negative swabs mentioned above; • No indications of respiratory distress; • Stability of hemodynamics
Continuing Care Follow-Up Suggestions
Complete the age-appropriate immunization schedule; administer erythromycin or penicillin for 14 days to household members and close contacts; and get follow-up nasopharyngeal cultures to verify the eradication of bacteria.
DIET: Pasteurization is recommended for all dairy products.
PATIENT EDUCATION • Completing the age-appropriate immunization schedule is crucial • Seeking treatment as soon as an infection is suspected
Cardiac involvement is linked to a very poor prognosis.
prognosis; bacteremia mortality rates of 30–40%; high mortality rates in individuals under age 5 and those over age 40
Problems include: septicemia or septic shock; septic arthritis, osteomyelitis; myocarditis, cardiac dilatation and failure, mycotic aneurysm, endocarditis; cardiac rhythm abnormalities; secondary bacterial pneumonia; cranial nerve dysfunction, peripheral neuropathies, and complete paralysis; optic neuritis; acute tubular necrosis; and septicemia or septic shock. Five to ten percent of respiratory cases result in death.
DIPHTHERIA
Basics: Obstructive laryngotracheitis, which can cause trouble breathing, or pseudomembrane formation on the tonsils, pharynx, larynx, and nasal cavity are signs of an acute upper respiratory tract infection caused by Corynebacterium diphtheriae. Acute tubular necrosis, peripheral neuropathies, and myocarditis are further possible outcomes of infection. C. diphtheriae can also produce lesser skin-only illnesses.
The study of epidemiology
Since 1980, the US has seen an incidence of about 0.001 instances per 100,000 people. Prior to vaccination, in the 1920s, there were between 100–200 cases per 100,000 people.
The frequency
Preschool-aged children have the highest attack rate; recent, infrequent outbreaks have mostly impacted adults; it is still endemic in portions of Africa, the Americas, the Middle East, Asia, the South Pacific, and Europe.
• It is more prevalent during the colder months in temperate zones; in the tropics, seasonal variations are less pronounced.
RISK ELEMENTS
Low socioeconomic position, lack of or insufficient immunization, crowded and filthy living conditions, immunocompromise, and travel to endemic or ongoing epidemic areas, particularly for those without a diphtheria toxoid booster
Genetics
No clear genetic connection to illness
GENERAL PREVENTION • Health education highlighting the risks of contracting diphtheria and the value of vaccination • Immunization with diphtheria toxoid
• Every ten years, diphtheria toxoid is promoted; the government is dedicated to immunization and other public health initiatives.
Tight disease control protocols during outbreaks: Notify the Department of Health of cases; isolate and treat patients
Clean all items that come into contact with the patient; isolate patient contacts who work with food, particularly milk, and those who come into contact with youngsters who are not inoculated; look into the cause of the infection; Preventive care for infection carriers
Pathophysiology
Exotoxin is released by C. diphtheria when it adheres to mucosal epithelial cells; it causes a local inflammatory response that is followed by tissue destruction and necrosis; it causes proteolytic cleavage of the cell membrane, which allows segment A to enter the cell; it inhibits host cell protein synthesis and results in cell death; and it spreads through the lymphatic and hematological systems, causing systemic disease.
Ethiology
• Caused by C. diphtheriae strains infected with a lysogenic bacteriophage virus that carries a gene that codes for a toxin.
• The incubation time is 2–5 days (with a range of 1–10).
C. diphtheriae are aerobic, pleomorphic, Gram-positive, nonmotile bacilli that mostly infect humans.
• The organism may colonize the respiratory tract without causing illness; it is spread via respiratory droplets, contact with nasopharyngeal secretions, exudates from cutaneous lesions, and fomites.
COMMON CONNECTED CIRCUMSTANCES
No conditions that are frequently linked
History of Diagnosis
• Signs, such as chills and fevers
Weakness and malaise; cough, hoarse voice, sore throat, and dysphagia Cervical lymphedema
- Headache - Serosanguineous or purulent nasal discharge - Neck edema - Nasopharyngeal membrane formation - Dyspnea, wheezing
Lesions on the skin
• Travel history; • Immunocompromising conditions; • History of vaccinations, including booster shots;
• Drinking unpasteurized dairy products
Physical examination • Fever of low severity
Swelling of the neck or "bull's neck"; tachycardia; pseudomembrane (grey and adherent) on the tonsils, pharynx, or nasal membranes; bleeding in the underlying mucosa when the pseudomembrane is scraped off; halitosis; cervical lymphadenopathy; respiratory distress symptoms such as stridor, wheeze, cyanosis, and use of accessory muscles; dysrhythmias; indications of infective endocarditis; and deficits in the cranium or peripheral nerves
Initial diagnostic and interpretation lab tests
Moderate leukocytosis is seen in the complete blood count (CBC); temporary proteinuria is seen in the urine analysis.
• Levels of serum troponin-I
• The isolation of C. diphtheriae in culture and the detection of toxin presence serve as the foundation for a conclusive diagnosis.
• C. diphtheriae was isolated using Gram stain, which revealed clusters of club-shaped, nonencapsulated, nonmotile bacilli with a distinctive Chinese character configuration.
Cultures: Use nasal or throat swabs to inoculate tellurite or Loeffler media, then identify the colonies based on their morphology, microscopic appearance, and fermentation reactions.
• Polymerase chain reaction (PCR) for tox genes; Elek test; Toxin detection
Follow-up and Particular Points to Remember
Keep an eye on your CBC and 12-lead ECG.
Imaging first approach: computed topography, ultrasound scan, or chest radiograph; soft tissue radiography of the neck
Follow-up and Particular Points to Remember
Nothing
Diagnostic Tests and Other Services: Patients may need:
Surgical airway procedures such as cricothyroidotomy or tracheostomy; laryngoscopy or bronchoscopy; endotracheal intubation; and electrical pacing for conduction problems
Pathological Results
The tonsils, pharynx, larynx, and nasal mucosa all have pseudomembranes, which can be aspirated into the lungs.
DISTINCTIVE DIAGNOSIS
Vincent's angina, viral pharyngitis, streptococcal pharyngitis, infectious mononucleosis, epiglottitis, infectious endocarditis, and herpes simplex virus
MEDICATION FOR TREATMENT
First Phrase
• Since horses produce diphtheria antitoxin (DAT) and patients may experience a hypersensitive reaction to horse antiserum, DAT should be given as soon as possible. With epinephrine and cardiac resuscitation resources nearby, a test dose is necessary.
• Antibiotics: Penicillin G 300,000 U/d for 14 days in patients under 10 kg i.m.
600,000 U/d for 14 days for patients weighing more than 10 kg i.m.
Erythromycin (for people who are allergic to penicillins) Adult: 500 mg intravenously every six hours for 14 days
Vancomycin for children: 40–50 mg/kg/day p.o./i.v., divided into 6 hourly doses for 14 days
Adult: given intravenously (1 g every 12 hours)
Children: intravenous infusion of 40 mg/kg/d over 1 hour, divided into 6 hourly doses; bronchodilators; antipyrexials; second-line pharmaceutical therapy as described above
ADDITIONAL MEDICATION
Overall Actions
Patients should be isolated as soon as possible. Two large-bore intravenous cannulae should be inserted. Cardiac monitoring should be done.
Referral issues include the following: anesthetist for airway management; surgery for surgical airway; cardiology for myocarditis; respiratory medication for bronchoscopy for pseudomembrane removal or obstruction; renal medication for acute tubular necrosis; and neurology for peripheral nerve damage.
ALTERNATIVE AND COMPLIMENTARY THERAPIES
Physiotherapy for neurological conditions
OTHER PROCEDURES AND SURGERY
Surgical airway may be necessary.
Considering the patient
First Stabilization
Provide patients with adequate resuscitation in accordance with pediatric basic life-support or advanced life support (ALS) procedures.
Requirements for Admission
Individuals with heart failure, septicemia, pulmonary compromise, or symptoms of infective endocarditis
IV fluids; aggressive fluid resuscitation in septic shock patients using colloids, such as Gelofusin
• When necessary, maintenance fluids containing Ringer's lactate
Until two nasopharyngeal swab cultures, obtained 24 and 48 hours after stopping antibiotics, are negative, nurses should isolate patients using universal and droplet precautions.
Criteria for Discharge
• Individuals with the two negative swabs mentioned above; • No indications of respiratory distress; • Stability of hemodynamics
Continuing Care Follow-Up Suggestions
Complete the age-appropriate immunization schedule; administer erythromycin or penicillin for 14 days to household members and close contacts; and get follow-up nasopharyngeal cultures to verify the eradication of bacteria.
DIET: Pasteurization is recommended for all dairy products.
PATIENT EDUCATION • Completing the age-appropriate immunization schedule is crucial • Seeking treatment as soon as an infection is suspected
Cardiac involvement is linked to a very poor prognosis.
prognosis; bacteremia mortality rates of 30–40%; high mortality rates in individuals under age 5 and those over age 40
Problems include: septicemia or septic shock; septic arthritis, osteomyelitis; myocarditis, cardiac dilatation and failure, mycotic aneurysm, endocarditis; cardiac rhythm abnormalities; secondary bacterial pneumonia; cranial nerve dysfunction, peripheral neuropathies, and complete paralysis; optic neuritis; acute tubular necrosis; and septicemia or septic shock. Five to ten percent of respiratory cases result in death.
0 Comments
